Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Manuel, Suarez Tembra"'
Autor:
Ricardo Gómez Huelgas, Juana Carretero Gómez, Jose Miguel Seguí Ripoll, Francisco Javier Carrasco-Sánchez, Juan Jesús Carabantes Rueda, Manuel Suarez Tembra, José Carlos Arévalo Lorido, José Manuel Casas Rojo, Javier Ena
Publikováno v:
Current Medical Research and Opinion. 37:1867-1873
To assess the efficacy of sodium-glucose cotransporter-2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptors agonist (GLP-1RA) therapy on liver steatosis measured by fatty liver index (FLI) and hepatic steatosis index (HSI) at 26 weeks in outpat
Autor:
Francisco Javier Carrasco-Sánchez, José Carlos Arévalo Lorido, Jose Miguel Segui-Ripoll, Javier Ena, Ricardo Gómez-Huelgas, Manuel Suarez Tembra, Juana Carretero Gómez, Jose Manuel Varela
Publikováno v:
Diabetes. 69
Aim: To analyze changes on UACR in T2DM patients according to treatment schedule groups (GLP-1RA or SGLT2i). Methods: Observational, prospective, multicenter study. Patients were stratified according to predetermined treatment schedule groups (succes
Autor:
Oup Diabetes, José Manuel Casas, José Miguel Seguí-Ripoll, Javier Carrasco, José Carlos Arévalo Lorido, Juana Carretero Gómez, Ricardo Gómez-Huelgas, Manuel Suarez Tembra
Publikováno v:
Diabetes. 68
Aim: To analyze changes in Fatty Liver Index (FLI) in obese and T2DM patients under treatment with GLP-1RA - SGLT2i combination. Methods: Observational, prospective, multicenter study. Patients were stratified according to predetermined treatment sch
Autor:
Sergi Bellmunt Montoya, Álvaro Fernández Heredero, Manuel Suarez Tembra, Guillermo Moñux Ducajú, Xavier Pintó, Melina Vega de Ceniga, Esther Bravo Ruiz, Carlos Guijarro, Marta Botas Velasco, Ángel Brea Hernando, Carlos Esteban Gracia, Carlos Lahoz, Leonardo Reinares García
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 28:1-49
Autor:
Sergi Bellmunt Montoya, Manuel Suarez Tembra, Esther Bravo Ruiz, Ángel Brea Hernando, Guillermo Moñux Ducajú, Carlos Guijarro, Carlos Esteban Gracia, Marta Botas Velasco, Álvaro Fernández Heredero, Melina Vega de Ceniga, Carlos Lahoz, Leonardo Reinares García, Xavier Pintó
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 27:159-165
Carlos Lahoza,∗, Carlos Esteban Graciab, Leonardo Reinares Garciac, Sergi Bellmunt Montoyad, Angel Brea Hernandoe, Alvaro Fernandez Herederof, Manuel Suarez Tembrag, Marta Botas Velascoh, Carlos Guijarro i, Esther Bravo Ruiz j, Xavier Pintok, Melin
Autor:
Carlos, Lahoz, Carlos, Esteban Gracia, Leonardo, Reinares García, Sergi, Bellmunt Montoya, Ángel, Brea Hernando, Álvaro, Fernández Heredero, Manuel, Suarez Tembra, Marta, Botas Velasco, Carlos, Guijarro, Esther, Bravo Ruiz, Xavier, Pintó, Melina, Vega de Ceniga, Guillermo, Moñux Ducajú
Publikováno v:
Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis. 27(3)
Autor:
José María, Mostaza, Carlos, Lahoz, Francisco, Morales-Olivas, Xavier, Pinto, Salvador, Tranche, Manuel, Suarez-Tembra, Teresa, Mantilla, Joan, Rius
Publikováno v:
Medicina clinica. 143(10)
Statins are safe but have a significant potential for pharmacological interactions. The objective of the study was to evaluate the prevalence of potential interactions throughout the cytochrome P450 isoenzyme 3A4 (CYP3A4) system in a large sample of